RecruitingPHASE1, PHASE2NCT07575971
Exploratory Study of CD22/CD19 Dual-Target CAR-T Cell Therapy as Consolidation Treatment After First Remission in High-Risk B-Cell Acute Lymphoblastic Leukemia
Studying Precursor B-cell acute lymphoblastic leukemia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Liping Dou
- Intervention
- CD22/CD19 Dual-Target CAR-T Cells(biological)
- Enrollment
- 30 enrolled
- Eligibility
- 18-85 years · All sexes
- Timeline
- 2026 – 2027
Study locations (1)
- Chinese PLA General Hospital, Beijing, Beijing Municipality, China
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT07575971 on ClinicalTrials.govOther trials for Precursor B-cell acute lymphoblastic leukemia
Additional recruiting or active studies for the same condition.
- RECRUITINGEARLY PHASE1NCT07470073A Clinical Study Exploring the Safety, Efficacy and Cell Metabolic Kinetics of Universal Car-t Cell Injection in CD19 and / or CD20 Positive Relapsed / Refractory B-cell Acute Lymphoblastic Leukemia in Adolescents, Children and AdultsUnion Hospital, Tongji Medical College, Huazhong University of Science and Technology
- RECRUITINGNANCT07371403MB-CART19.1 in Relapsed/Refractory Acute Lymphoblastic LeukemiaKing Hussein Cancer Center
- RECRUITINGPHASE3NCT07441291CD19 CAR-T vs DLI for Post-HSCT MRD in Ph- ALL: A RCTPeking University People's Hospital
- ACTIVE NOT RECRUITINGNCT07269587A Real-world Study on the Treatment of Adult B-cell Acute Lymphoblastic Leukemia With CNCT-19Ruijin Hospital
- RECRUITINGPHASE1NCT07066397A Phase 1 Study of FIT-CD19-CAR-T Cells in R/R B-ALLTriArm Therapeutics (Taiwan) Limited
- RECRUITINGPHASE2NCT06985485Full-Course Immunotherapy Consolidation for Unfit or Fit B-ALL Who Decline ChemotherapyThe First Affiliated Hospital of Soochow University
- RECRUITINGNANCT07003737Blinatumomab Intensification for MRD-Negative Acute B-Cell Lymphoblastic Leukemia Before Allogeneic Hematopoietic Stem Cell TransplantationFirst Affiliated Hospital of Zhejiang University
- RECRUITINGPHASE2NCT06533748Therapy for Newly Diagnosed Patients With B-Cell Precursor Acute Lymphoblastic Leukemia and LymphomaSt. Jude Children's Research Hospital
See all trials for Precursor B-cell acute lymphoblastic leukemia →